• A+
• A+
• A+

Adjust font size

Namenda

This WisdomCard managed by: Tara Salamone

Namenda is a brand name for the drug memantine. Namenda is in a class of drugs called NMDA receptor antagonists, which are used in the treatment of moderate to severe Alzheimer's disease. Namenda operates by protecting the brain's nerve cells against excessive amounts of glutamate in the brain. Glutamate is a chemical messenger released in large amounts by cells damaged by Alzheimer’s disease and other neurological disorders. For complete information, see the Memantine WisdomCard.

What is Namenda?

• Namenda Mementine HCl
• American Society of Health-System Pharmacists (via Medline Plus): Memantine
• Mayo Clinic: Memantine (Oral Route)
• WebMD: Namenda Oral
• RxList: Namenda
• Drugs.com: Namenda
• Drug Digest: Namenda
• Wikipedia: Memantine

Sponsored Links

5 Latest Headlines on Namenda

Namenda - Google News Wyeth Test May Reveal False Promise in Alzheimer's (Update3) - Bloomberg Alzheimer's Drug May Prevent Brain Damage in Preemies - Scientific American Early diagnosis lets Alzheimer's patients get ahead of disease - Edmonton Journal Symptoms suggest advanced Alzheimer's - Reading Eagle Earnings up, earnings down for drugmakers - FiercePharma

• More Namenda News from Google News

Company Information on Namenda

• Forest Pharmaceuticals, Inc.

Related WisdomCards

• Alzheimer's
• Alzheimer's Disease Treatment
• Cholinesterase Inhibitors
• Razadyne
• Exelon
• Cognex
• Alzheimer's Disease Genetics
• Alzheimer's Personal Stories
• Alzheimer's Disease Support Groups and Message Boards
• Famous People with Alzheimer's

User Recommended Links for Namenda

Are we missing any great links? Please Login or Register to be the first to add to this list of recommended links to help others and improve this WisdomCard.